Nasser K. Altorki

Cornell University ORCID: 0000-0001-9754-9945

3

h-index

3

Publications

3,498

Citations

Publications

3 shown

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

Enriqueta Felip , Nasser K. Altorki , Caicun Zhou +18 more

2021 The Lancet 1356 citations

The lung microenvironment: an important regulator of tumour growth and metastasis

Nasser K. Altorki , Geoffrey J. Markowitz , Dingcheng Gao +5 more

2018 Nature reviews. Cancer 1128 citations

TOX is a critical regulator of tumour-specific T cell differentiation

Peter Lauer , Olivier Levy , Michael S. Glickman +24 more

2019 Nature 1014 citations

Frequent Co-Authors

Enriqueta Felip

Vall d'Hebron Institute of Oncology

Caicun Zhou

Shanghai Pulmonary Hospital

Tibor Csőszi

Université Toulouse III - Paul Sabatier

Ihor Vynnychenko

Sumy State University

Oleksandr Goloborodko

National University Zaporizhzhia Polytechnic

Alexander Luft

Leningrad Regional Cancer Center

Researcher Info

h-index: 3
Publications: 3
Citations: 3,498
Institution: Cornell University

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-9754-9945

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.

Academic Output Over Time